LQDA - Liquidia Corporation
NASDAQ
->
Healthcare
->
Biotechnology
Morrisville,
United States
Type: Equity
LQDA price evolution
LQDA
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $133.09 | $157.86 | $83.68 | |
| Short term investments | ||||
| Net receivables | $4.2 | $3.25 | $2.57 | $4.06 |
| Inventory | $0.04 | $7.21 | $3.52 | |
| Total current assets | $214.21 | $147.26 | $167.94 | $89.9 |
| Long term investments | ||||
| Property, plant & equipment | $9.15 | $7.86 | $7.17 | $6.18 |
| Goodwill & intangible assets | $7.2 | $7.28 | $7.33 | |
| Total noncurrent assets | $30.1 | $29.18 | $28.43 | |
| Total investments | ||||
| Total assets | $252.89 | $177.36 | $197.12 | $118.33 |
| Current liabilities | ||||
| Accounts payable | $2.3 | $5.74 | $2.49 | $1.4 |
| Deferred revenue | ||||
| Short long term debt | $5.38 | $5.37 | $3.75 | |
| Total current liabilities | $33.84 | $24.22 | $21.93 | $18.55 |
| Long term debt | $99.89 | $83.49 | $82.22 | $45.78 |
| Total noncurrent liabilities | $90.42 | $88.93 | $52.49 | |
| Total debt | $88.87 | $87.59 | $49.54 | |
| Total liabilities | $142.37 | $114.64 | $110.86 | $71.04 |
| Shareholders' equity | ||||
| Retained earnings | -$521.12 | -$497.97 | -$470.03 | -$429.1 |
| Other shareholder equity | ||||
| Total shareholder equity | $62.72 | $86.26 | $47.29 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $83.68 | $93.28 | $57.49 | $65.32 |
| Short term investments | ||||
| Net receivables | $4.06 | $5.02 | $2.99 | |
| Inventory | ||||
| Total current assets | $89.9 | $99.81 | $61.28 | $66.07 |
| Long term investments | ||||
| Property, plant & equipment | $6.18 | $6.25 | $7.43 | $9.45 |
| Goodwill & intangible assets | $7.33 | $7.63 | $8.29 | $9.44 |
| Total noncurrent assets | $28.43 | $29.39 | $32.45 | $33.46 |
| Total investments | ||||
| Total assets | $118.33 | $129.2 | $93.73 | $99.53 |
| Current liabilities | ||||
| Accounts payable | $1.4 | $2.2 | $1.07 | $3.73 |
| Deferred revenue | ||||
| Short long term debt | $3.75 | $1.08 | $1.09 | $1.59 |
| Total current liabilities | $18.55 | $8.8 | $7.33 | $11.74 |
| Long term debt | $45.78 | $20.05 | $14.99 | $15.55 |
| Total noncurrent liabilities | $52.49 | $29.98 | $21.14 | $16.71 |
| Total debt | $49.54 | $24.46 | $16.08 | $17.14 |
| Total liabilities | $71.04 | $38.78 | $28.46 | $28.45 |
| Shareholders' equity | ||||
| Retained earnings | -$429.1 | -$350.6 | -$309.58 | -$275 |
| Other shareholder equity | ||||
| Total shareholder equity | $47.29 | $90.42 | $65.27 | $71.09 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3.66 | $2.97 | $4.53 | |
| Cost of revenue | $1.49 | $1.47 | $0.99 | |
| Gross Profit | $2.17 | $1.5 | $3.54 | |
| Operating activities | ||||
| Research & development | $9.42 | $10.06 | $12.83 | |
| Selling, general & administrative | $19.94 | $20.25 | $17.14 | |
| Total operating expenses | $29.36 | $30.31 | $29.97 | |
| Operating income | -$27.2 | -$28.8 | -$26.44 | |
| Income from continuing operations | ||||
| EBIT | -$25.34 | -$38.4 | -$25.49 | |
| Income tax expense | ||||
| Interest expense | $2.6 | $2.52 | $1.96 | |
| Net income | ||||
| Net income | -$27.94 | -$40.93 | -$27.45 | |
| Income (for common shares) | -$27.94 | -$40.93 | -$27.45 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $17.49 | $15.94 | $12.85 | $0.74 |
| Cost of revenue | $2.89 | $2.86 | $3.02 | $0.24 |
| Gross Profit | $14.6 | $13.08 | $9.83 | $0.5 |
| Operating activities | ||||
| Research & development | $43.24 | $19.43 | $20.52 | $32.22 |
| Selling, general & administrative | $44.74 | $32.41 | $23.11 | $27.37 |
| Total operating expenses | $87.98 | $51.85 | $43.63 | $59.59 |
| Operating income | -$73.38 | -$38.77 | -$33.8 | -$59.09 |
| Income from continuing operations | ||||
| EBIT | -$72.23 | -$38.68 | -$33.76 | -$58.9 |
| Income tax expense | ||||
| Interest expense | $6.27 | $2.34 | $0.82 | $0.86 |
| Net income | ||||
| Net income | -$78.5 | -$41.02 | -$34.58 | -$59.76 |
| Income (for common shares) | -$78.5 | -$41.02 | -$34.58 | -$59.76 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$27.94 | -$40.93 | -$27.45 | |
| Operating activities | ||||
| Depreciation | $0.7 | $0.6 | $0.61 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $4.37 | $4.52 | $2.55 | |
| Total cash flows from operations | -$22.66 | -$24.87 | -$15.98 | |
| Investing activities | ||||
| Capital expenditures | -$1.29 | -$0.62 | -$0.21 | |
| Investments | ||||
| Total cash flows from investing | -$3.66 | -$1.29 | -$0.62 | -$0.21 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.03 | $75.37 | $24.32 | |
| Net borrowings | -$1.06 | $24.3 | -$0.68 | |
| Total cash flows from financing | $196.96 | -$0.81 | $99.67 | $23.64 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $120.69 | -$24.77 | $74.18 | $7.45 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$78.5 | -$41.02 | -$34.58 | -$59.76 |
| Operating activities | ||||
| Depreciation | $2.58 | $3.96 | $5.85 | $3.3 |
| Business acquisitions & disposals | $1 | |||
| Stock-based compensation | $10.09 | $9.3 | $6.75 | $3.95 |
| Total cash flows from operations | -$41.56 | -$28.59 | -$34.04 | -$54.14 |
| Investing activities | ||||
| Capital expenditures | -$1.29 | -$0.59 | -$0.11 | -$0.75 |
| Investments | ||||
| Total cash flows from investing | -$11.29 | -$0.59 | -$0.11 | $0.25 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $25.42 | $55.56 | $21.75 | $71.31 |
| Net borrowings | $19.91 | $8.96 | -$0.42 | -$6.77 |
| Total cash flows from financing | $43.25 | $64.96 | $26.32 | $63.42 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$9.6 | $35.79 | -$7.82 | $9.52 |
News
Fundamentals
| Market cap | $3.94B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 84.55M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.50 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 6.33 |
| Quick ratio | 6.33 |